Clinical Trial Update: Avatrombopag to Promote Platelet Engraftment After Allo-HSCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating avatrombopag to promote platelet engraftment after allogeneic hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Hematopoietic Stem Cell Transplantation-related Thrombocytopenia
• Platelet Disorder

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Platelet Disorder | Phase 2 | Status: UNKNOWN